glp-1 etf HRTS is the World's First | Tema Insights GLP-1 2.0: Where the Next
Description
"GLP-1s may offer a dual benefit for patients with chronic conditions like diabetes or obesity who are also struggling with a substance use disorder: one medication can treat both conditions at once," Al-Aly said
2014;9(3):e91163
Their depression improves in ways that seem to go beyond what youd expect from weight loss or appetite suppression alone
N Engl J Med 381(9): 841 851 Fudim M, White J, Pagidipati NJ, Lokhnygina Y, Wainstein J, Murin J, Iqbal N, hman P, Lopes RD, Reicher B, Holman RR, Hernandez AF, Mentz RJ (2019) Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial
strong clinical trial backing for cardiovascular and kidney benefits Emarketer
GLP-1RAs have revolutionized the field of weight loss therapy
